BTK Inhibitors in Multiple Sclerosis Treatment
Neurology® Podcast · American Academy of Neurology
April 21, 202521m 3s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.